Virtual Reality for Urological Procedures
Feasibility of a Virtual Reality Intervention for Patients Undergoing Urological Procedures
1 other identifier
interventional
100
1 country
1
Brief Summary
It is standard practice for most cystoscopies and vasectomies in an office or outpatient setting to be performed under local anesthesia while the patient is awake and conscious. However, given the conscious nature of these procedures, patients may experience anxiety-inducing stressors that they otherwise would not under general anesthesia. Stressors such as hearing surgical terminology, technical discussion, and injection of local anesthetic have been previously documented as sources of perioperative anxiety and pain in awake surgeries. The current study will examine the feasibility and pilot outcomes of Virtual Reality (VR) guided meditation therapy during cystoscopies and vasectomies. Feasibility will be examined through: (1) recruitment capability and resulting sample characteristics, (2) data collection procedures (including randomization) and outcome measures, and (3) participant acceptability and suitability of the VR intervention during the procedures. The investigators will also evaluate pilot outcomes of the VR intervention on pain, anxiety, and overall satisfaction with the procedure. Results of this study will inform the development of a large-scale randomized clinical trial (RCT) to evaluate the efficacy of this intervention. Participants will be asked to complete questionnaires before and after their procedure and will be asked for a verbal measure of their pain and anxiety during the procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 6, 2024
CompletedFirst Submitted
Initial submission to the registry
July 12, 2024
CompletedFirst Posted
Study publicly available on registry
August 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedJanuary 23, 2025
August 1, 2024
5 months
July 12, 2024
January 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Recruitment rate
Proportion of individuals who consent to participation and the number of recruited participants per week
through study completion, up to 1 year
Inclusion criteria and demographic and surgery-related differences
Proportion of individuals who meet inclusion criteria and any demographic and surgery-related differences in potentially eligible participants
through study completion, up to 1 year
Retention of participants in the study
Proportion of individuals who tolerate the intervention and complete the study
Immediate post-operative
Acceptability through elevate scores on the Virtual Reality Impression Scale
Acceptability of the VR program during urological procedures (0 thru 100, 100=positive impressions)
Immediate post-operative
Impressions of the VR based on open-ended responses on the Virtual Reality Impression Scale
Negative and positive impressions of the VR intervention (open ended/qualitative)
Immediate post-operative
Secondary Outcomes (9)
Scores on the National Comprehensive Cancer Network (NCCN) Distress Thermometer (and adapted Anxiety Thermometer)
Pre-operative, acute post-operative (immediately following surgery)
Visual Analogue Scale pain severity
Peri-operative (mid-way through procedure)
Visual Analogue Scale anxiety severity
Peri-operative (mid-way through procedure)
State Trait Anxiety Inventory (STAI) elevated scores
Pre-operative, acute post-operative (immediately following surgery)
PROMIS Pain Intensity Scale total score
Acute post-operative (immediately following surgery)
- +4 more secondary outcomes
Study Arms (4)
Cystoscopy VR intervention
EXPERIMENTALLocal anesthetic and VR intervention
Cystoscopy treatment as usual
ACTIVE COMPARATORLocal anesthetic only
Vasectomy VR intervention
EXPERIMENTALLocal anesthetic and VR intervention
Vasectomy treatment as usual
ACTIVE COMPARATORLocal anesthetic only
Interventions
Tripp application on Meta Quest 3 VR headset
No VR, local anesthetic only
Eligibility Criteria
You may qualify if:
- years of age or older
- can speak and read English
- have an indication for a cystoscopy or elected for a vasectomy
- are scheduled to undergo their respective procedure under local anesthesia at the Men's Health Clinic between the dates of May-November 2024.
You may not qualify if:
- those who are not competent to provide informed consent (e.g., due to cognitive impairment)
- those who are unable to participate in a VR intervention (e.g., due to visual or auditory impairment)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Men's Health Clinic
Winnipeg, Manitoba, R3P 2S8, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Renée El-Gabalawy, PhD
University of Manitoba
- PRINCIPAL INVESTIGATOR
Premal Patel, MD
University of Manitoba
- PRINCIPAL INVESTIGATOR
Simone Gentile, BSc
University of Manitoba
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 12, 2024
First Posted
August 2, 2024
Study Start
June 6, 2024
Primary Completion
November 1, 2024
Study Completion
November 1, 2024
Last Updated
January 23, 2025
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share